summit tirzepatide Impact of Obesity Severity on the Effects of in HFpEF: The Trial Tirzepatide Reduces Heart Failure Events

SKU: 76358715794

Pay in 4 interest-free payments of $6.92 Learn more

Live Spec

Tirzepatide Reduces Heart Failure Events in HFpEF With Obesity SUMMIT: Tirzepatide Reduces Cardiovascular Events in HFpEF Plus Obesity 60 Second Journal Club: The SUMMIT trial examined cardiovascular outcomes of treatment with tirzepatide in patients with heart failure with preserved ejection fraction and obesity. Read the full trial GLP 1based drug tirzepatide reduces heart risk in high risk patients EurekAlert! SUMMIT: Benefits From Tirzepatide Similar By Sex in Patients With Obesity Related HFpEF American College of Cardiology 408. Journal Club: The SUMMIT Trial with Dr. Milton Packer

Store: lestom-kurzy.sk · Domain: lestom-kurzy.sk